NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 257)
Posted On: 10/03/2018 4:48:04 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Extends List of Applicable Uses for Innovative Drug Delivery Platform
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) continues to leverage its drug delivery platform technology in exciting new markets. An article discussing the company reads, “It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to the OTC Markets’ OTCQX Best Market, Lexaria Bioscience is based in Kelowna, British Columbia. … The DehydraTECH™ drug delivery platform promotes healthier ingestion methods. It considerably improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other valuable molecules. The platform boosts the performance of useful compounds in ingestible products across the taste, smell, speed of action, bioabsorption and bioavailability categories.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) continues to leverage its drug delivery platform technology in exciting new markets. An article discussing the company reads, “It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to the OTC Markets’ OTCQX Best Market, Lexaria Bioscience is based in Kelowna, British Columbia. … The DehydraTECH™ drug delivery platform promotes healthier ingestion methods. It considerably improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other valuable molecules. The platform boosts the performance of useful compounds in ingestible products across the taste, smell, speed of action, bioabsorption and bioavailability categories.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)